Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01170507

Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation

Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation: A Randomized Controlled Study

Status
Withdrawn
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Vitamin D deficiency is common world wide. 25 OH vitamin D level is the best indicator of vitamin D status. The determination of the appropriate dose of vitamin D supplement is essential for management of vitamin D deficiency as well as for designing vitamin D fortification programs. The increments in 25 OH vitamin D levels following various doses of vitamin D supplement for different genders, body weights, and starting 25 OH vitamin D level have not been well defined. The time course of depletion of repleted vitamin D stores is also not known. The investigators plan to conduct a double blind randomized study on 9 cohorts to determine levels of 25 OH vitamin D following supplementation with different doses of vitamin D3 for 5 months and their withdrawal for 3 months.

Conditions

Interventions

TypeNameDescription
DRUGvitamin D3 1000 IU orally daily for 5 months
DRUGvitamin D3 3000 IU orally daily for 5 months
DRUGvitamin D3 5000 IU orally daily for 5 months
DRUGPlacebo orally daily for 5 months

Timeline

Start date
2011-12-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2010-07-27
Last updated
2018-03-07

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT01170507. Inclusion in this directory is not an endorsement.